Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges
Abstract Cannabidiol (CBD), a major non-psychotropic component of cannabis, is receiving growing attention as a potential anticancer agent. CBD suppresses…
Abstract Cannabidiol (CBD), a major non-psychotropic component of cannabis, is receiving growing attention as a potential anticancer agent. CBD suppresses…
Abstract The antineoplastic effects of cannabis have been known since 1975. Since the identification of the components of the endogenous…
Abstract Gender differences in psychiatric disorders and drug use are well known. Cannabis is the most widely used illegal drug…
Abstract Background: Δ9-tetrahydrocannabinol (THC) is the main psychoactive component and one of the most important medicinal compounds in cannabis. Whether…
Abstract Aim: We undertook this systematic review to determine the efficacy and safety of cannabis-based medicine as a treatment for…
Abstract Simple Summary: Neurodegenerative diseases represent an important cause of morbidity and mortality worldwide. Existing therapeutic options are limited and…
Abstract Cancer patients often use cannabinoids for alleviating symptoms induced by cancer pathogenesis and cancer treatment. This use of cannabinoids…
Abstract Many people worldwide use plant preparations for medicinal purposes. Even in industrialized regions, such as Europe, where conventional therapies…
Abstract Drugs that target the endocannabinoid system are of interest as pharmacological options to combat cancer and to improve the…
Abstract Objectives: The optimal treatment strategy for cholecystocholedocholithiasis is still controversial. We conducted an up-to-date meta-analysis to compare the efficacy…